Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $6.34 Million - $6.92 Million
-20,500 Reduced 45.05%
25,000 $8.06 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $25 Million - $30.3 Million
-95,000 Reduced 67.62%
45,500 $14.2 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $28.7 Million - $34.6 Million
106,600 Added 314.45%
140,500 $39.9 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $3.81 Million - $4.3 Million
14,900 Added 78.42%
33,900 $9.76 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $85,708 - $101,348
400 Added 2.15%
19,000 $4.22 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $722,528 - $880,640
3,200 Added 20.78%
18,600 $4.5 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $1.24 Million - $1.57 Million
5,400 Added 54.0%
15,400 $4.04 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $4.67 Million - $5.27 Million
-20,800 Reduced 67.53%
10,000 $2.25 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $2.91 Million - $3.23 Million
-12,600 Reduced 29.03%
30,800 $7.49 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $3.95 Million - $4.37 Million
18,000 Added 70.87%
43,400 $10.5 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $19,888 - $22,760
100 Added 0.4%
25,400 $5.71 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $4.2 Million - $4.92 Million
19,800 Added 360.0%
25,300 $5.38 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $9.97 Million - $11.1 Million
-42,700 Reduced 88.59%
5,500 $1.34 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $10.5 Million - $12.3 Million
47,400 Added 5925.0%
48,200 $12 Million
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $187,720 - $208,760
-800 Reduced 50.0%
800 $203,000
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $278,576 - $333,792
1,600 New
1,600 $310,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.